Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

BACKGROUND: Data on the use of ceftolozane-tazobactam and emergence of ceftolozane-tazobactam resistance during multidrug resistant (MDR)-Pseudomonas aeruginosa infections are limited. METHODS: We performed a retrospective study of 21 patients treated with ceftolozane-tazobactam for MDR-P. aeruginos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Haidar, Ghady, Philips, Nathan J, Shields, Ryan K, Snyder, Daniel, Cheng, Shaoji, Potoski, Brian A, Doi, Yohei, Hao, Binghua, Press, Ellen G, Cooper, Vaughn S, Clancy, Cornelius J, Nguyen, M Hong
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848332/
https://ncbi.nlm.nih.gov/pubmed/29017262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados